Current report filing

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2015
Jun. 30, 2015
Jun. 30, 2014
Current assets      
Cash and cash equivalents $ 194,263 $ 229,046 $ 51,179
Short-term deposits 54,620 55,292  
Accounts receivable, net of allowance for doubtful accounts of $-, $- and $- (including amounts due from related parties of $2,000, $3,000 and $11,000) 744 4 138
Other current assets and prepaid expenses (including current portion of clinical materials) 13,420 10,740 2,990
Total current assets 263,047 295,082 54,307
Restricted cash 4,508    
Clinical materials 4,736    
Property, plant and equipment, net 13,225 5,393 1,428
Intangibles, net 305 178  
Total assets 285,821 300,653 55,735
Current liabilities      
Accounts payable (including amounts due to related parties of $-, $143,000 and $194,000) 7,884 1,982 1,010
Accrued expenses and other accrued liabilities (including amounts due to related parties of $288,000, $2,000 and $-) 7,518 3,877 9,978
Deferred revenue 12,487 20,906 41,790
Total current liabilities 27,889 26,765 52,778
Deferred revenue, less current portion 22,939 14,885  
Total liabilities 50,828 41,650 52,778
Contingencies and commitments - Note 8
Equity      
Common stock - Ordinary shares par value GBP 0.001, 574,711,900 authorized and 424,711,900 issued and outstanding (June 30, 2015: 574,711,900 authorized and 424,711,900 issued and outstanding, June 30, 2014: 211,139,700 authorized and 181,370,100 issued and outstanding) 682 682 291
Additional paid in capital 332,363 328,795 32,512
Accumulated other comprehensive (loss) income (8,139) (3,561) 274
Accumulated deficit (89,913) (66,913) (30,120)
Total equity 234,993 259,003 2,957
Total liabilities and stockholders' equity $ 285,821 $ 300,653 $ 55,735